Atlas Trials

Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock

Clinical trial NCT05813951 · UNKNOWN

Trial details

NCT number
NCT05813951
Sponsor
Ain Shams University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Treatment Efficacy
Start date
2022-12-02
Primary completion
2023-12-02
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.